Loss of the constitutive endothelial anticoagulants such as TFPI, EPCR, and thrombomodulin is an important component of the prothrombotic endothelial transformation and may be an underappreciated driver of COVID-19 coagulopathy. The gene discussed is PROCR; the disease is blood coagulation disease.